STOPCAP M1
Menu
  • Home
  • What is STOPCAP M1?
    • Systematic reviews
      • The FAME approach
      • Docetaxel
      • Zoledronic acid
      • Abiraterone
      • Prostate RT
      • Network
    • Surrogate outcomes
      • ICECAP M0
    • Repository of patient data
  • Who is running STOPCAP M1?
    • Programme Management Group
    • International Advisory Group
    • Key Collaborators
    • Collaborative Group
  • Patient & Public Involvement
    • PPI and STOPCAP M1
    • Recent STOPCAP M1 results
    • Prostate Cancer Resources
  • News
  • Sitemap

What is STOPCAP M1?

Who is running STOPCAP M1?

Patient & public involvement

News


Latest News

Most men with advanced prostate cancer benefit from new generation hormone therapy drugs

Our latest STOPCAP results presented at ASCO GU 2025

More

STOPCAP M1

MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ

Email. mrcctu.stopcapm1@ucl.ac.uk

Twitter. https://twitter.com/MRCCTU

Quick links

  • Publications
  • Protocol
Funded by PCUK

Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887.
  • © 2025
  • Sitemap
  • Cookies
  • RSS
  • Page last updated: 01-Feb-2023 13:32